GET THE APP

Europäisches Journal für klinische Onkologie

ISSN - 2732-2654

Volumen 6, Ausgabe 1 (2024)

Perspektive

Advancing Hematologic Cancer Treatment: The Promise of CAR-T Cell Therapy

Albert Kevin

Perspektive

Advancing Hematologic Cancer Treatment: The Promise of CAR-T Cell Therapy

Albert Kevin

Perspektive

Advancing Hematologic Cancer Treatment: The Promise of CAR-T Cell Therapy

Albert Kevin

Perspektive

Advancing Hematologic Cancer Treatment: The Promise of CAR-T Cell Therapy

Albert Kevin

Perspektive

Advancing Hematologic Cancer Treatment: The Promise of CAR-T Cell Therapy

Albert Kevin

Perspektive

Therapeutic Agents Targeting Gene Expression Modifications, Epigenetic Drugs Show Promise in Treating Diseases Like Cancer and Neurological Disorders, Crucial for Precision Medicine Advancements

Allen Robert

Perspektive

Therapeutic Agents Targeting Gene Expression Modifications, Epigenetic Drugs Show Promise in Treating Diseases Like Cancer and Neurological Disorders, Crucial for Precision Medicine Advancements

Allen Robert

Perspektive

Therapeutic Agents Targeting Gene Expression Modifications, Epigenetic Drugs Show Promise in Treating Diseases Like Cancer and Neurological Disorders, Crucial for Precision Medicine Advancements

Allen Robert

Perspektive

Therapeutic Agents Targeting Gene Expression Modifications, Epigenetic Drugs Show Promise in Treating Diseases Like Cancer and Neurological Disorders, Crucial for Precision Medicine Advancements

Allen Robert

Perspektive

Therapeutic Agents Targeting Gene Expression Modifications, Epigenetic Drugs Show Promise in Treating Diseases Like Cancer and Neurological Disorders, Crucial for Precision Medicine Advancements

Allen Robert

Forschung

Computational Explorations in Biomedicine: Unraveling Molecular Dynamics for Cancer, Drug Delivery, and Biomolecular Insights using LAMMPS Simulations

Reza Bozorgpour

Forschung

Computational Explorations in Biomedicine: Unraveling Molecular Dynamics for Cancer, Drug Delivery, and Biomolecular Insights using LAMMPS Simulations

Reza Bozorgpour

Forschung

Computational Explorations in Biomedicine: Unraveling Molecular Dynamics for Cancer, Drug Delivery, and Biomolecular Insights using LAMMPS Simulations

Reza Bozorgpour

Forschung

Computational Explorations in Biomedicine: Unraveling Molecular Dynamics for Cancer, Drug Delivery, and Biomolecular Insights using LAMMPS Simulations

Reza Bozorgpour

Forschung

Computational Explorations in Biomedicine: Unraveling Molecular Dynamics for Cancer, Drug Delivery, and Biomolecular Insights using LAMMPS Simulations

Reza Bozorgpour

Forschungsartikel

The Importance of Fourier-Transformed Infrared Spectroscopy (FT-IR) In The Diagnosis of Stomach Cancer

Yilmaz Sahin, Mevlut Albayrak

Forschungsartikel

The Importance of Fourier-Transformed Infrared Spectroscopy (FT-IR) In The Diagnosis of Stomach Cancer

Yilmaz Sahin, Mevlut Albayrak

Forschungsartikel

The Importance of Fourier-Transformed Infrared Spectroscopy (FT-IR) In The Diagnosis of Stomach Cancer

Yilmaz Sahin, Mevlut Albayrak

Forschungsartikel

The Importance of Fourier-Transformed Infrared Spectroscopy (FT-IR) In The Diagnosis of Stomach Cancer

Yilmaz Sahin, Mevlut Albayrak

Forschungsartikel

The Importance of Fourier-Transformed Infrared Spectroscopy (FT-IR) In The Diagnosis of Stomach Cancer

Yilmaz Sahin, Mevlut Albayrak

Kurze Kommunikation

The Introduction of Nivolumab Plus Ipilimumab in the Treatment of aRCC Patients: Differences Between Low- and High-Volume Centers in Germany

Marcus Derigs, Günter Niegisch, Tobias R. Richter, Benedikt Mönig, Rene Mage, Axel Hegele, Thomas Steiner, Viktor Grünwald and Philipp Ivanyi

Kurze Kommunikation

The Introduction of Nivolumab Plus Ipilimumab in the Treatment of aRCC Patients: Differences Between Low- and High-Volume Centers in Germany

Marcus Derigs, Günter Niegisch, Tobias R. Richter, Benedikt Mönig, Rene Mage, Axel Hegele, Thomas Steiner, Viktor Grünwald and Philipp Ivanyi

Kurze Kommunikation

The Introduction of Nivolumab Plus Ipilimumab in the Treatment of aRCC Patients: Differences Between Low- and High-Volume Centers in Germany

Marcus Derigs, Günter Niegisch, Tobias R. Richter, Benedikt Mönig, Rene Mage, Axel Hegele, Thomas Steiner, Viktor Grünwald and Philipp Ivanyi

Kurze Kommunikation

The Introduction of Nivolumab Plus Ipilimumab in the Treatment of aRCC Patients: Differences Between Low- and High-Volume Centers in Germany

Marcus Derigs, Günter Niegisch, Tobias R. Richter, Benedikt Mönig, Rene Mage, Axel Hegele, Thomas Steiner, Viktor Grünwald and Philipp Ivanyi

Kurze Kommunikation

The Introduction of Nivolumab Plus Ipilimumab in the Treatment of aRCC Patients: Differences Between Low- and High-Volume Centers in Germany

Marcus Derigs, Günter Niegisch, Tobias R. Richter, Benedikt Mönig, Rene Mage, Axel Hegele, Thomas Steiner, Viktor Grünwald and Philipp Ivanyi